BioStock: Eventful 2020 on many levels for Chordate Medical

The year is coming to an end, and it is time to look back at what has been an intense 2020 for Chordate Medical. Despite encountering some setbacks, the company has made significant progress in its rhinitis and migraine projects. BioStock has contacted Chordate Medical’s CEO, Anders Weilandt, to hear what he has to say about the past year and the plans for 2021.

Read the full article at biostock.se:

https://www.biostock.se/en/eventful-2020-on-many-levels-for-chordate-medical/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se